SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumab [Yahoo! Finance]
Hercules Capital, Inc. (HTGC)
Last hercules capital, inc. earnings: 2/20 04:10 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.htgc.com
Company Research
Source: Yahoo! Finance
Provides flexible loan facility to support additional clinical work and activities to drive its successful registration and commercialisation Funding is additional to recent $75m Series B financing DUBLIN and OXFORD, England April 30, 2024 /PRNewswire/ -- SynOx Therapeutics Limited ("SynOx" or the "Company"), the late-stage clinical biopharmaceutical company developing emactuzumab for the treatment of Tenosynovial Giant Cell Tumour (TGCT) and other diseases, today announces it has entered into a $35m loan facility with Hercules Capital, Inc. (NYSE: HTGC) ("Hercules"). The transaction strengthens the Company's balance sheet as it executes TANGENT, a registrational Phase 3 study of emactuzumab, SynOx's potentially best-in-class CSF-1(R) inhibiting monoclonal antibody (mAb) for the treatment of TGCT. This loan facility provides SynOx with flexibility to fund additional clinical work in TGCT to augment TANGENT, activities to support the successful registration and commercialisati
Show less
Read more
Impact Snapshot
Event Time:
HTGC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HTGC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HTGC alerts
High impacting Hercules Capital, Inc. news events
Weekly update
A roundup of the hottest topics
HTGC
News
- Hercules Capital Announces Date of 2024 Annual Meeting of Stockholders [Yahoo! Finance]Yahoo! Finance
- Hercules Capital Announces Date of 2024 Annual Meeting of StockholdersBusiness Wire
- bluebird (BLUE) Tops on Q1 Sales, Zynteglo Progresses Well [Yahoo! Finance]Yahoo! Finance
- Hercules Capital: Solid 10% Yield, But Sky-High Valuation [Seeking Alpha]Seeking Alpha
- bluebird bio Reports First Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance [Yahoo! Finance]Yahoo! Finance
HTGC
Earnings
- 5/2/24 - Beat
HTGC
Sec Filings
- 5/2/24 - Form 8-K
- 5/2/24 - Form 10-Q
- 4/23/24 - Form DEF
- HTGC's page on the SEC website